Apathy diagnosis, assessment, and treatment in Alzheimer's disease

CNS Neuroscience and Therapeutics

Volumn 16, Issue 5, 2010, Pages 263-271

  Robert, Philippe H ^a   Mulin, Emmanuel ^a   Malléa, Patrick ^a   David, Renaud ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Alzheimer's disease; Apathy; Diagnostic criteria; Neuropsychiatry; Neurotransmitters; Pharmacological treatment

Indexed keywords

AMANTADINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; GINKGO BILOBA EXTRACT; LEVODOPA; MEMANTINE; METHYLPHENIDATE; PAROXETINE; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 2C AGONIST; SEROTONIN 3 AGONIST; TIANEPTINE; NEUROLEPTIC AGENT;

AGED; AGING; ALZHEIMER DISEASE; ANXIETY; APATHY; BECK DEPRESSION INVENTORY; BRAIN; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG EFFICACY; EMOTION; FRONTAL LOBE; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MOTIVATION; NEUROLOGIC DISEASE; NEUROPHARMACOLOGY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NONHUMAN; OUTCOMES RESEARCH; REVIEW; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME; DRUG EFFECT; MOOD DISORDER; PHYSIOLOGY;

ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; APATHY; HUMANS; MOOD DISORDERS; MOTIVATION;

EID: 77956399340     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2009.00132.x     Document Type: Review

References (78)

1. Robert P, Verhey F, Byrne EJ, et al. Grouping for behavioral and psychological symptoms in dementia: Clinical and biological aspects. Consensus paper of the European Alzheimer Disease Consortium. Eur Psychiatry 2005 20 : 490 496.
2. Starkstein SE, Leentjens AFG. The nosological position of apathy. J Neurol Neurosurg Psychiatry 2008 79 : 1088 1092.
3. Marin RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991 3 : 243 254.
4. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry 1990 147 : 22 30.
5. Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B. Apathy: A treatable syndrome. J Neuropsychiatry Clin Neurosci 1995 7 : 23 30.
6. Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001 158 : 872 877.
7. Brown RG, Pluck G. Negative symptoms: The pathology of motivation and goal-directed behavior. Trends Neurosci 2000 23 : 412 417.
8. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006 16 : 916 928.
9. Stuss DT, Van Reekum R, Murphy KJ. Differentiation of states and causes of apathy. In : Borod J, editor. The neuropsychology of emotion. New York : Oxford University Press, 2000.
10. Van Reekum R, Stuss DT, Ostrander R. Apathy: Why care? J Neuropsychiatry Clin Neurosci 2005 17 : 7 19.
11. Lopez OL, Becker JT, Sweet RA. Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase 2005 11 : 65 71.
12. Feldman H, Scheltens P, Scarpini E, et al. Behavioral symptoms in mild cognitive impairment. Neurology 2004 62 : 1199 1201.
13. Gabryelewicz T, Styczynska M, Pfeffer A, et al. Prevalence of major and minor depression in elderly persons with mild cognitive impairment-MADRS factor analysis. Int J Geriatr Psychiatry 2004 19 : 1168 1172.
14. Sarazin M, Berr C, De Rotrou J, et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology 2007 69 : 1859 1867.
15. Robert P, Berr C, Volteau M, et al. Neuropsychological performance in mild cognitive impairment with and without apathy. Dement Geriatr Cogn Dis 2006 21 : 192 197.
16. Robert PH, Berr C, Volteau M, et al. Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry 2008 16 : 770 776.
17. Vicini Chilovi B, Conti M, Zanetti M, Mazzu I, Rozzini L, Padovani A. Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2009 27 : 390 398.
18. Gonfrier S, Andrieu S, David R, et al. Course of neuropsychiatric symptoms during a four year follow-up in the REAL-FR cohort. The Journal of the Alzheimer's Association 2008 4 (4 Suppl 2 135.
19. Boyle PA, Malloy PF. Treating apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2004 17 : 91 99.
20. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006 77 : 8 11.
21. Lechowski L, Benoit M, Chassagne P, et al. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: The REAL longitudinal cohort study. Int J Geriatri Psychiatry 2009 24 : 341 346.
22. Drijgers RL, Aalten P, Wionogrodzka A, Verhey FRJ, Leentjens AFG. Pharmacological treatment of apathy in neurodegenerative diseases: A systematic review. Dement Geriatr Cogn Disord 2009 28 : 13 22.
23. Lu PH, Edland E, Tingus K, Petersen RC, Cummings JL Alzheimer's Disease Cooperative Study Group. Donepezil delays progression to AD in MCI with depressive symptoms. Neurology 2009 72 : 2115 2121.
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Am J Geriatr Psychiatry 1961 4 : 561 571.
25. Bartolini M, Coccia M, Luzzi S, Provinciali L, Ceravolo MG. Motivational symptoms of depression mask preclinical Alzheimer's disease in elderly subjects. Dement Geriatr Cogn Disord 2005 19 : 31 36.
26. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Bäckman L. The occurrence of depressive symptoms in the preclinical phase of AD. A population-based study. Neurology 1999 53 : 1998 2002.
27. Robert PH, Onyike CU, Leentjens AFG, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. European Psychiaty 2009 24 : 98 104.
28. Starkstein SE, Ingram L, Garau ML, Mizrahi R. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry 2005 76 : 1070 1074.
29. Benoit M, Andrieu S, Lechowski L, Gillette-Guyonnet S, Robert PH, Vellas B. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatric Psychiatry 2008 23 : 409 414.
30. Cummings JL, Mega MS, Gray K, Rosemberg-Thompson S, Gornbein T. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994 44 : 2308 2314.
31. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991 38 : 143 162.
32. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992 4 : 134 139.
33. Robert PH, Clairet S, Benoit M, et al. The Apathy Inventory: Assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatric Psychiatry 2002 17 : 1099 1105.
34. Sockeel P, Dujardin K, Devos D, Denève C, Destée A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: Validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006 77 : 579 584.
35. Yesavage JA, Friedman L. A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients. J Geriatr Psychiatry Neurol 1998 11 : 7 10.
36. Mahlberg R, Walther S. Actigraphy in agitated patients with dementia: Monitoring treatment outcomes. Z Gerontol Geriatr 2007 40 : 178 184.
37. Mulin E, David R, Rivet A, et al. Apathy assessment using ambulatory actigraphy short-time recording in mild Alzheimer's disease. Int Psychogeriatrics Assoc 2009 21 : S116.
38. Lavretsky H. Neuropsychiatric symptoms in Alzheimer disease and related disorders: Why do treatments work in clinical practice but not in the randomized trials? Am J Geriatr Psychiatry 2008 16 : 523 527.
39. Craig AH, Cummings JL, Fairbanks L, et al. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neuro 1996 53 : 1116 1120.
40. Benoit M, Dygai I, Migneco O, et al. Behavioral and psychological symptoms in Alzheimer's disease. Dement Geriatr Cogn Dis 1999 10 : 511 517.
41. Migneco O, Benoît M, Koulibaly PM, et al. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients. NeuroImage 2001 13 : 896 902.
42. Benoit M, Clairet S, Koulibaly M, Darcourt J, Robert PH. Brain perfusion correlates of the Apathy Inventory dimensions in Alzheimer's disease. Int J Geriatric Psychiary 2004 19 : 864 869.
43. Benoit M, Koulibaly PM, Migneco O, Darcourt J, Pringuey DJ, Robert PH. Brain perfusion in Alzheimer's disease with and without apathy: A SPECT study with statistical parametric mapping analysis. Psychiatry Res: Neuroimaging 2002 114 : 103 111.
44. Holthoff V, Baumann B, Kalbe E, et al. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry 2005 57 : 412 421.
45. Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008 131 : 2455 2463.
46. Jack CRJ, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005 65 : 1227 1231.
47. Shino A, Watababe T, Maeda K, Kotani E, Akiguchi I, Matsuda M. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 2006 33 : 17 26.
48. Schultz W. The primate basal ganglia and the voluntary control of behaviour. J Consc Stud 1999 6 : 31 45.
49. Rolls E. The brain and emotion. Oxford : Oxford University Press, 1999.
50. Berridge KC, Robinson TE. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998 28 : 309 369.
51. Berridge KC. Food reward: Brain substrates of wanting and liking. Neurosci Biobehav Rev 1996 20 : 1 25.
52. Blackburn JR, Phillips AG, Jakubovic A, Fibiger HC. Dopamine and preparatory behavior. Behav Neurosci 1989 103 : 15 23.
53. Toates F. Motivational systems. Cambridge : Cambridge University Press, 1986.
54. Berridge KC. Comparing the emotional brains of humans and other animals. In : Davidson R, Goldsmith H, Scherer K, editors. Handbook of affective sciences. Oxford : Oxford University Press, 2003 25 51.
55. Berridge KC, Robinson T. Parsing reward. Trends Neurosci 2003 26 : 507 513.
56. Robert P, Darcourt G, Koulibaly M, et al. Lack of initiative and interest in Alzheimer's disease. A single photon computed tomography study. European Neurol 2006 13 : 729 735.
57. David R, Koulibaly MP, Benoit M, et al. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases. A SPECT study with partial volume effect correction. Clin Neurol Neurosurg 2007 110 : 19 24.
58. Volkow ND, Logan J, Fowler JS, et al. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 2000 157 : 75 80.
59. Zhou FM, Wilson CJ, Dani JA. Cholinergic interneuron characteristics and nicotinic properties in the striatum. Neurobiology 2002 53 : 590 605.
60. Martorana AF, Mori Z, Esposito H, et al. Dopamine modulates cholinergic cortical excitability in Alzheimer's patients. Neuropsychopharmacology 2009 34 : 2323 2328.
61. Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996 153 : 466 476.
62. Korsgaard S, Gerlach J, Christensson E. Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur J Pharmacol 1985 118 : 245 252.
63. Sasaki-Adams DM, Kelley AE. Serotonin-dopamine interactions in the control of reinforcement and motor behavior. Neuropsychopharmacology 2001 25 : 440 452.
64. 3 receptor involvement in alcohol dependence: A microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. Alcohol Clin Exp Res 1996 20 : 311A 319A.
65. De Deurwaerdere P, Bonhomme N, Lucas G, Le Moal M, Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J Neurochem 1996 66 : 210 215.
66. Hallbus M, Magnusson T, Magnusson O. Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: A microdialysis study. Neurosci Lett 1997 225 : 57 60.
67. Walsh SL, Cunningham KA. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 1997 130 : 41 58.
68. De Deurwaerdere P, Stinus L, Spampinato U. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: Role of 5-HT3 receptors. J Neurosci 1998 18 : 6528 6538.
69. Ugedo L, Grenhoff J, Svensson TH. Ritanserin, a 5-HT2 receptor antagonist, activate midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989 98 : 45 50.
70. Kapur S, Zipursky RB, Remington G. Comparison of the 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia: Clinical and theoretical implications. Am J Psychiatry 1999 156 : 286 293.
71. Millan MJ, Dekeyne A, Gobert A. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 1998 37 : 953 955.
72. Park SB, Coull JT, McShane RH, et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 1994 33 : 575 588.
73. Rogers RD, Blackshaw AJ, Middleton HC, et al. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) 1999 146 : 482 491.
74. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nature Neurosci 2004 7 : 887 893.
75. Smith GS, Kramer E, Yilong MA, et al. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain 2009 132 : 392 401.
76. Dranovsky A, Hen R. Hippocampal neurogenesis: Regulation by stress and antidepressants. Biol Psychiatry 2006 59 : 1136 1143.
77. Mowla A, Mosavinasab M, Haghshenas H, Haghighi AB. Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 2007 27 : 484 487.
78. Kessing LV, Sondergard L, Forman JL, Andersen PK. Antidepressants and dementia. J Affect Disord 2009 117 : 24 29.